Duragen® Secure Post Marketing Clinical Follow-up (PMCF)

Duragen® Secure Post Marketing Clinical Follow-up (PMCF)

The purpose of this study is to gather information about post-market performance of DuraGen Secure.The aim of this post market clinical follow-up (PMCF) is to obtain post market clinical data to evaluate the presence of unintended residual risks associated with the use of DuraGen Secure that were not anticipated or identified in the animal studies, bench studies or clinical evaluation report.

Inclusion Criteria:

• Patient who have undergone a neurosurgical procedure where DuraGen® Secure has been implanted

Exclusion Criteria:

• Patient who does not agree to allow collection of his/her medical data